18/06/2026
Could your asthma inhaler help protect the planet?
If you use a steroid inhaler for mild to moderate asthma, you may be eligible to participate in the TRECONY clinical study.
This study is evaluating an investigational asthma inhaler that uses a new, climate-friendly propellant. Researchers will compare it to a currently available inhaler to assess its safety and effectiveness while exploring a more environmentally conscious alternative for asthma care.
✔ Ages 18 to 75
✔ Diagnosed with mild to moderate asthma (at least 6 months before age 50)
✔ Regularly uses a steroid inhaler
✔ Study duration of approximately 20 weeks
✔ 8 study visits
✔ Non-smoker or ex-smoker
By taking part, you could help advance asthma treatment while contributing to a more sustainable future.
Contact Tiervlei Trial Centre to find out if you may qualify.
7th Floor, The View, Tygervalley Health Centre, 43 Old Oak Road, Bellville, 7530 | Office Number: 021 957 9400 | E-mail: [email protected] | Website: www.ttc-trials.co.za